Madison, WI, United States of America

Elsebet Lund

This inventor holds 2 USPTO granted patents. Top assignee: Wisconsin Alumni Research Foundation. Active years: 1999-2010.


% Patents Active = 50.0

Average Co-Inventor Count = 4.4

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 1999-2010

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Elsebet Lund

Introduction

Elsebet Lund is a notable inventor based in Madison, WI (US). She has made significant contributions to the field of medical diagnostics and treatment, particularly in relation to B-cell lymphoma. With a total of 2 patents, her work has the potential to impact veterinary medicine and cancer research.

Latest Patents

One of Elsebet Lund's latest patents is the miR-155 assay. This invention provides methods for diagnosing B-cell lymphoma in animals. It specifically distinguishes between animals with diffuse large B-cell lymphoma (DLBCL) that have an activated B-cell (ABC) phenotype and those with a non-activated germinal-center (GC) phenotype. Additionally, this invention offers methods for identifying compounds that can treat B-cell lymphoma. It also includes reagents and methods for determining the amount of miR-155 in samples isolated from animals, utilizing a set of oligonucleotides for accurate measurement.

Another significant patent is the method of inhibition of nucleo-cytoplasmic transport by M protein. This method involves inhibiting the transport of nucleic acids between the nucleus and cytoplasm of a cell. In one embodiment, the method requires exposing a cell to a sufficient amount of vesicular stomatitis virus M protein, which impedes the transport of RNA and protein through the nuclear envelope. This patent also discloses a chimeric RNA capable of nuclear export.

Career Highlights

Elsebet Lund is associated with the Wisconsin Alumni Research Foundation, where she continues to innovate and contribute to scientific advancements. Her work is characterized by a strong focus on improving diagnostic methods and therapeutic options for B-cell lymphoma.

Collaborations

Elsebet has collaborated with notable colleagues, including James E. Dahlberg and Peggy S. Eis. Their combined expertise enhances the research and development of innovative solutions in their field.

Conclusion

Elsebet Lund's contributions to the field of medical diagnostics and treatment exemplify the impact of innovation in addressing complex health issues. Her patents reflect a commitment to advancing veterinary medicine and cancer research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…